View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Diabetes News

SPONSORED CONTENT
September 18, 2024
2 min read
Save
GLP-1RA use linked to lower risk for cirrhosis, mortality in MASLD with diabetes

GLP-1RA use linked to lower risk for cirrhosis, mortality in MASLD with diabetes

Use of glucagon-like peptide-1 receptor agonists was associated with a reduced risk for progression to cirrhosis and other complications in patients with metabolic dysfunction-associated steatotic liver disease and diabetes, data showed.

SPONSORED CONTENT
September 18, 2024
1 min read
Save

Top in endocrinology: Type 1 diabetes progression in children; tubeless insulin patch pump

Top in endocrinology: Type 1 diabetes progression in children; tubeless insulin patch pump

Higher consumption of rye, oats and fruits increased the risk for progression to type 1 diabetes among children at high genetic risk for the disease, study results showed.

SPONSORED CONTENT
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
September 16, 2024
3 min read
Save

Wegovy improves heart-related outcomes in obesity regardless of kidney function

Wegovy improves heart-related outcomes in obesity regardless of kidney function

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.

SPONSORED CONTENT
September 13, 2024
2 min read
Save

Tirzepatide tied to lower odds for diabetic retinopathy, pancreatitis than GLP-1s

Tirzepatide tied to lower odds for diabetic retinopathy, pancreatitis than GLP-1s

Tirzepatide is associated with similar odds for gastrointestinal adverse events and a lower likelihood for diabetic retinopathy and pancreatitis compared with GLP-1 receptor agonists, according to a presenter.

SPONSORED CONTENT
September 12, 2024
2 min read
Save

Eating more meat may increase risk for developing type 2 diabetes

Eating more meat may increase risk for developing type 2 diabetes

Adults who eat greater amounts of meat may have increased risk for developing type 2 diabetes, according to data published in The Lancet Diabetes & Endocrinology.

SPONSORED CONTENT
September 11, 2024
2 min read
Save

Top in endocrinology: PFAS exposure during pregnancy; once-weekly insulin

Top in endocrinology: PFAS exposure during pregnancy; once-weekly insulin

Exposure to high amounts of certain per- and polyfluoroalkyl substances during pregnancy may cause long-term increases in weight and fat mass, according to research published in The Journal of Clinical Endocrinology & Metabolism.

SPONSORED CONTENT
September 10, 2024
2 min read
Save

Diabetes drug linked to reduced risk for several types of dementia

Diabetes drug linked to reduced risk for several types of dementia

Type 2 diabetes has emerged as a possible risk factor contributing to the development of dementia, but one class of agents used to treat the disease may provide greater protective effects, study results published in BMJ showed.

SPONSORED CONTENT
September 04, 2024
2 min read
Save

Top in endocrinology: Omnipod 5 for type 2 diabetes; single-dose vials of tirzeptaide

Top in endocrinology: Omnipod 5 for type 2 diabetes; single-dose vials of tirzeptaide

The FDA has cleared a tubeless automated insulin delivery system indicated for adults with type 2 diabetes.

SPONSORED CONTENT
September 04, 2024
4 min read
Save

‘Reassuring’ findings suggest GLP-1 receptor agonists do not increase suicide risk

‘Reassuring’ findings suggest GLP-1 receptor agonists do not increase suicide risk

Results from two studies found no association between the use of GLP-1 receptor agonists and increased risk for suicide, suicidal thoughts or depression, findings published in JAMA Internal Medicine showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails